OpenLegislation

Regulation 18 Marking of bottles and other containers

United Kingdom

(1)

Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—

(a)

in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;

(b)

in the case of a controlled drug which is a preparation—

(i)

made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;

(ii)

not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.

(2)

Nothing in this regulation shall have effect in relation to—

(a)

the drugs specified in Schedules 4 and 5 or poppy-straw;

(b)

any drug specified in Schedule 3 contained in or comprising a preparation which—

(i)

is required for use as a buffering agent in chemical analysis;

(ii)

has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and

(iii)

is premixed in a kit;

(c)

any exempt product;

F1(d)

the supply of a controlled drug by or on the prescription of a practitioner, a supplementary prescriber, a nurse independent prescriber F2, registered chiropodist or registered podiatrist, paramedic independent prescriber, therapeutic radiographer independent prescriber or a pharmacist independent prescriber;

(e)

the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.

F3(3)

In this regulation—

  • F4...

  • “medicinal test on animals” has the same meaning as in the Medicines Act 1968.

Annotations

Textual amendments

F1

Reg. 18(2)(d) substituted (23.4.2012) by The Misuse of Drugs (Amendment No.2) (England, Wales and Scotland) Regulations 2012 (S.I. 2012/973), regs. 1(1), 13

F2

Words in reg. 18(2)(d) inserted (31.12.2023) by The Misuse of Drugs (England and Wales and Scotland) (Amendment) (No. 2) Regulations 2023 (S.I. 2023/1345), regs. 1(2), 10

F3

Reg. 18(3) substituted (1.5.2004) by The Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031), reg. 1, Sch. 10 Pt. 2 para. 16

F4

Words in reg. 18(3) omitted (1.11.2018) by virtue of The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 (S.I. 2018/1055), regs. 1(1), 5